Shine-On Biomedical Co., Ltd. (6926) Stock Statistics & Valuation Metrics
Total Valuation
Shine-On Biomedical Co., Ltd. has a market cap or net worth of TWD 2.76B. The enterprise value is ―.
- Market Cap
- TWD 2.76B
- Enterprise Value
- ―
Share Statistics
Shine-On Biomedical Co., Ltd. has 49,800,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 49,800,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Shine-On Biomedical Co., Ltd.’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -13.79%.
- Return on Equity (ROE)
- -0.12
- Return on Assets (ROA)
- -0.12
- Return on Invested Capital (ROIC)
- -13.79%
- Return on Capital Employed (ROCE)
- -0.14
- Revenue Per Employee
- 1.36M
- Profits Per Employee
- -5.01M
- Employee Count
- 22
- Asset Turnover
- 0.03
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Shine-On Biomedical Co., Ltd. is -16.14. Shine-On Biomedical Co., Ltd.’s PEG ratio is 0.26.
- PE Ratio
- -16.14
- PS Ratio
- 57.95
- PB Ratio
- 3.71
- Price to FCF
- -20.31
- Price to Operating Cash Flow
- -20.46
- PEG Ratio
- 0.26
Income Statement
In the last 12 months, Shine-On Biomedical Co., Ltd. had revenue of 30.00M and earned -110.28M in profits. Earnings per share was -2.21.
- Revenue
- 30.00M
- Gross Profit
- 27.93M
- Operating Income
- -125.50M
- Pretax Income
- -110.42M
- Net Income
- -110.28M
- EBITDA
- -123.43M
- Earnings Per Share (EPS)
- -2.21
Cash Flow
In the last 12 months, operating cash flow was -143.38M and capital expenditures -1.05M, giving a free cash flow of -144.43M billion.
- Operating Cash Flow
- -143.38M
- Free Cash Flow
- -144.43M
- Free Cash Flow per Share
- -2.90
Dividends & Yields
Shine-On Biomedical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4.92%
- Earnings Yield
- -6.20%
Stock Price Statistics
- Beta
- 0.15
- 52-Week Price Change
- -23.24%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 25.88
- Average Volume (3m)
- 13.62K
Financial Position
Shine-On Biomedical Co., Ltd. as a current ratio of 21.48, with Debt / Equity ratio of 0.15%
- Current Ratio
- 21.48
- Quick Ratio
- 21.48
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.39
- Interest Coverage Ratio
- -4648.07
Taxes
In the past 12 months, Shine-On Biomedical Co., Ltd. has paid -134.00K in taxes.
- Income Tax
- -134.00K
- Effective Tax Rate
- 0.00
Enterprise Valuation
Shine-On Biomedical Co., Ltd. EV to EBITDA ratio is -14.82, with an EV/FCF ratio of -19.89.
- EV to Sales
- 56.74
- EV to EBITDA
- -14.82
- EV to Free Cash Flow
- -19.89
- EV to Operating Cash Flow
- -20.03
Balance Sheet
Shine-On Biomedical Co., Ltd. has TWD 808.81M in cash and marketable securities with TWD 680.00K in debt, giving a net cash position of TWD 808.13M billion.
- Cash & Marketable Securities
- TWD 808.81M
- Total Debt
- TWD 680.00K
- Net Cash
- TWD 808.13M
- Net Cash Per Share
- TWD 16.23
- Tangible Book Value Per Share
- TWD 15.71
Margins
Gross margin is 95.78%, with operating margin of -387.09%, and net profit margin of -359.00%.
- Gross Margin
- 95.78%
- Operating Margin
- -387.09%
- Pretax Margin
- -358.95%
- Net Profit Margin
- -359.00%
- EBITDA Margin
- -382.87%
- EBIT Margin
- -387.09%
Analyst Forecast
The average price target for Shine-On Biomedical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -55.21%
